Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claudia Andreetta
Observed names:
Andreetta Claudia,
C Andreetta,
C. Andreetta
Institutions:
Ospedale Santa Maria della Misericordia di Udine,
Azienda sanitaria universitaria Friuli Centrale
Observed institutions:
University of Udine,
Centre Léon Bérard,
Royal Marsden Hospital,
Ospedale Santa Maria della Misericordia di Udine,
Azienda sanitaria universitaria Friuli Centrale
ORCID:
0000-0002-0470-043X
Observed ORCID:
0000-0002-0470-043X
OpenAlex ID:
A5066280513
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
2014
·
Marta Bonotto
, Lorenzo Gerratana
, et al.
·
The Oncologist
·
311
PDF
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2023
·
Ana Oaknin
, Laurence Gladieff
, et al.
·
The Lancet
·
270
PDF
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications
2005
·
F. Puglisi
, A. Follador
, et al.
·
Annals of Oncology
·
160
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
2019
·
T. Bachelot
, E. Ciruelos
, et al.
·
Annals of Oncology
·
119
PDF
Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines
2023
·
Stefano Restaino
, Chiara Paglietti
, et al.
·
Cancers
·
116
PDF
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
2021
·
D. Miles
, E. Ciruelos
, et al.
·
Annals of Oncology
·
103
PDF
Expression of periostin in human breast cancer
2007
·
F Puglisi
, C Puppin
, et al.
·
Journal of Clinical Pathology
·
92
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
2008
·
C. Andreetta
, C. Puppin
, et al.
·
Annals of Oncology
·
63
PDF
How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature
2024
·
Martina Arcieri
, Veronica Tius
, et al.
·
Frontiers in Oncology
·
49
PDF
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity
2024
·
Anna Passarelli
, Vittoria Carbone
, et al.
·
Gynecologic Oncology
·
48
PDF
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
2008
·
F. Puglisi
, G.G. Cardellino
, et al.
·
Annals of Oncology
·
44
PDF
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
2024
·
S. Pignata
, D. Califano
, et al.
·
Annals of Oncology
·
40
PDF
Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study
2008
·
Alessandro M. Minisini
, Sara De Faccio
, et al.
·
Critical Reviews in Oncology/Hematology
·
38
First-line chemotherapy with or without biologic agents for metastatic breast cancer
2010
·
Claudia Andreetta
, Alessandro M. Minisini
, et al.
·
Critical Reviews in Oncology/Hematology
·
37
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
2020
·
Michele Bartoletti
, Roberta Mazzeo
, et al.
·
International Journal of Gynecological Cancer
·
36
PDF
Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era
2009
·
Alessandro Marco Minisini
, Jessica Menis
, et al.
·
Anti-Cancer Drugs
·
33
Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer
2008
·
Alessandro M Minisini
, Claudia Andreetta
, et al.
·
Expert Review of Anticancer Therapy
·
23
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer
2007
·
Valentina Guarneri
, Antonio Frassoldati
, et al.
·
Breast Cancer Research and Treatment
·
23
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells
2007
·
Fabio Puglisi
, Claudia Andreetta
, et al.
·
Anti-Cancer Drugs
·
21
Markers of the uPA System and Common Prognostic Factors in Breast Cancer
2007
·
Alessandro Marco Minisini
, Dora Fabbro
, et al.
·
American Journal of Clinical Pathology
·
21
Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
2023
·
Gabriella Macchia
, Francesca Titone
, et al.
·
Healthcare
·
19
PDF
Comparison of Primary Breast Cancer and Paired Metastases: Biomarkers Discordance Influence on Outcome and Therapy
2018
·
Elena Ongaro
, Lorenzo Gerratana
, et al.
·
Future Oncology
·
18
Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer
2024
·
Martina Arcieri
, Tommaso Occhiali
, et al.
·
European Journal of Surgical Oncology
·
16
PDF
Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy
2011
·
Manuela Miscoria
, Fabrizio Tonetto
, et al.
·
Anti-Cancer Drugs
·
16
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
2021
·
Valentina Guarneri
, Carlo Alberto Giorgi
, et al.
·
European Journal of Cancer
·
13
PDF
Show more works
View as search
Works count:
101
Citation count:
1,887
H-index:
20
I10-index:
27
Year
Topic
Type